Keyphrases
Patient-centered Approach
100%
Podcast
100%
Vernal Keratoconjunctivitis
100%
Allergy
18%
Daily Activities
18%
Shield Ulcer
18%
Severe Disease
9%
Quality of Life
9%
Redness
9%
Asthma
9%
Vision Impairment
9%
Treatment Strategy
9%
Older Adults
9%
Atopic Asthma
9%
High Incidence
9%
Patient Care
9%
Co-treatment
9%
Psychological Well-being
9%
Ophthalmologist
9%
Challenging Conditions
9%
Topical Therapy
9%
Atopic Dermatitis
9%
Dermatologist
9%
Allergic Sensitization
9%
Cyclosporine
9%
Multidisciplinary Team
9%
Pediatricians
9%
Control Method
9%
Overall Well-being
9%
Distress Symptoms
9%
Rhinoconjunctivitis
9%
Itch
9%
Global Prevalence
9%
Related Conditions
9%
Eye Drops
9%
Economic Factors
9%
Ocular Inflammation
9%
House Dust Mite
9%
Stepwise Approach
9%
Ocular Surface
9%
Antiallergic Eye Drops
9%
Inhaled Allergens
9%
Team Collaboration
9%
Allergic Conjunctivitis
9%
Steroid Eye Drops
9%
Atopic Keratoconjunctivitis
9%
Giant Papillae
9%
Corneal Complications
9%
Medicine and Dentistry
Vernal Keratoconjunctivitis
100%
Disease
27%
Wellbeing
18%
Sensitization
18%
Ulcer
18%
Ocular Surface
18%
Quality of Life
9%
Symptom
9%
Asthma
9%
Prevalence
9%
Patient Care
9%
Visual Impairment
9%
Atopic Dermatitis
9%
Allergen
9%
Cyclosporine
9%
Clinical Finding
9%
Allergic Asthma
9%
Pediatrician
9%
Topical Agent
9%
Rhinoconjunctivitis
9%
Antiallergic
9%
Allergic Conjunctivitis
9%
Atopic Keratoconjunctivitis
9%
Nursing and Health Professions
Vernal Conjunctivitis
100%
Disease
27%
Ulcer
18%
Symptom
9%
Quality of Life
9%
Asthma
9%
Inflammation
9%
Patient Care
9%
Prevalence
9%
Visual Impairment
9%
Pediatrician
9%
Atopic Dermatitis
9%
Ciclosporin
9%
Allergen
9%
Dermatologist
9%
Ophthalmologist
9%
Allergic Asthma
9%
Topical Agent
9%
Rhinoconjunctivitis
9%
Atopic Keratoconjunctivitis
9%
Allergic Conjunctivitis
9%
Pharmacology, Toxicology and Pharmaceutical Science
Vernal Conjunctivitis
100%
Disease
27%
Ulcer
18%
Inflammation
9%
Symptom
9%
Prevalence
9%
Asthma
9%
Visual Impairment
9%
Allergic Asthma
9%
Allergen
9%
Ciclosporin
9%
Rhinoconjunctivitis
9%
Atopic Dermatitis
9%
Topical Agent
9%
Antiallergic
9%
Dermatophagoides
9%
Atopic Keratoconjunctivitis
9%
Allergic Conjunctivitis
9%
Immunology and Microbiology
Vernal Conjunctivitis
100%
Surface Property
18%
Sensitization
18%
Wellbeing
18%
Prevalence
9%
Asthma
9%
Allergen
9%
Atopic Dermatitis
9%
Allergic Asthma
9%
Ciclosporin
9%
Dermatophagoides
9%
Allergic Conjunctivitis
9%
Atopic Keratoconjunctivitis
9%